Fidelity Investments’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-6,366,185
Closed -$190M 2902
2014
Q3
$190M Sell
6,366,185
-937,350
-13% -$19.9M 0.03% 680
2014
Q2
$147M Buy
7,303,535
+1,243,836
+21% +$28.5M 0.02% 801
2014
Q1
$165M Buy
6,059,699
+2,674,090
+79% +$71M 0.02% 725
2013
Q4
$70.2M Buy
3,385,609
+832,300
+33% +$15.7M 0.01% 1145
2013
Q3
$46.5M Buy
2,553,309
+1,448,399
+131% +$26.2M 0.01% 1316
2013
Q2
$18.4M Buy
+1,104,910
New +$17.6M ﹤0.01% 1691

Other funds holding AUXL

Fidelity Investments's AUXL Position: Q4 2014 in Review

Fidelity Investments sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2014, closing a stake of 6,366,185 shares — an estimated $190M sold.

Fidelity Investments first reported a position in AUXL in Q2 2013 and held it in 6 quarters. The position peaked at $190M in Q3 2014. 158 funds tracked by Wall St. Rank hold AUXL as of Q4 2014.

  • Fidelity Investments reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Fidelity Investments sold 6,366,185 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2014, an estimated $190M.
  • Fidelity Investments first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • Fidelity Investments's AUXILIUM PHARAMCEUTICALS INC position peaked at $190M in Q3 2014.
  • 158 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2014.

Based on Fidelity Investments's 13F filing for Q4 2014, filed 17 Feb 2015.